PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
OLMA vs. DAC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


OLMADAC
YTD Return-15.47%13.63%
1Y Return-28.51%28.04%
3Y Return (Ann)-24.91%9.36%
Sharpe Ratio-0.331.10
Sortino Ratio-0.011.68
Omega Ratio1.001.20
Calmar Ratio-0.290.31
Martin Ratio-0.842.96
Ulcer Index29.26%8.85%
Daily Std Dev75.46%23.85%
Max Drawdown-96.26%-99.42%
Current Drawdown-78.24%-80.34%

Fundamentals


OLMADAC
Market Cap$679.18M$1.59B
EPS-$2.04$29.29
Total Revenue (TTM)$1.88M$736.49M
Gross Profit (TTM)$1.61M$449.69M
EBITDA (TTM)-$98.02M$340.85M

Correlation

-0.50.00.51.00.1

The correlation between OLMA and DAC is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

OLMA vs. DAC - Performance Comparison

In the year-to-date period, OLMA achieves a -15.47% return, which is significantly lower than DAC's 13.63% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%JuneJulyAugustSeptemberOctoberNovember
8.81%
5.41%
OLMA
DAC

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OLMA vs. DAC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and Danaos Corporation (DAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OLMA
Sharpe ratio
The chart of Sharpe ratio for OLMA, currently valued at -0.33, compared to the broader market-4.00-2.000.002.00-0.33
Sortino ratio
The chart of Sortino ratio for OLMA, currently valued at -0.01, compared to the broader market-4.00-2.000.002.004.00-0.01
Omega ratio
The chart of Omega ratio for OLMA, currently valued at 1.00, compared to the broader market0.501.001.502.001.00
Calmar ratio
The chart of Calmar ratio for OLMA, currently valued at -0.29, compared to the broader market0.002.004.006.00-0.29
Martin ratio
The chart of Martin ratio for OLMA, currently valued at -0.84, compared to the broader market-10.000.0010.0020.0030.00-0.84
DAC
Sharpe ratio
The chart of Sharpe ratio for DAC, currently valued at 1.10, compared to the broader market-4.00-2.000.002.001.10
Sortino ratio
The chart of Sortino ratio for DAC, currently valued at 1.68, compared to the broader market-4.00-2.000.002.004.001.68
Omega ratio
The chart of Omega ratio for DAC, currently valued at 1.20, compared to the broader market0.501.001.502.001.20
Calmar ratio
The chart of Calmar ratio for DAC, currently valued at 0.72, compared to the broader market0.002.004.006.000.72
Martin ratio
The chart of Martin ratio for DAC, currently valued at 2.96, compared to the broader market-10.000.0010.0020.0030.002.96

OLMA vs. DAC - Sharpe Ratio Comparison

The current OLMA Sharpe Ratio is -0.33, which is lower than the DAC Sharpe Ratio of 1.10. The chart below compares the historical Sharpe Ratios of OLMA and DAC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
-0.33
1.10
OLMA
DAC

Dividends

OLMA vs. DAC - Dividend Comparison

OLMA has not paid dividends to shareholders, while DAC's dividend yield for the trailing twelve months is around 3.91%.


TTM202320222021
OLMA
Olema Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%
DAC
Danaos Corporation
3.91%4.12%5.70%2.01%

Drawdowns

OLMA vs. DAC - Drawdown Comparison

The maximum OLMA drawdown since its inception was -96.26%, roughly equal to the maximum DAC drawdown of -99.42%. Use the drawdown chart below to compare losses from any high point for OLMA and DAC. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-78.24%
-14.48%
OLMA
DAC

Volatility

OLMA vs. DAC - Volatility Comparison

Olema Pharmaceuticals, Inc. (OLMA) has a higher volatility of 11.36% compared to Danaos Corporation (DAC) at 7.34%. This indicates that OLMA's price experiences larger fluctuations and is considered to be riskier than DAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
11.36%
7.34%
OLMA
DAC

Financials

OLMA vs. DAC - Financials Comparison

This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and Danaos Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items